Literature DB >> 2767221

Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.

G Palù1, S Valisena, M F Barile, G A Meloni.   

Abstract

Ureaplasma urealyticum is considered as a species which is intrinsically sensitive to macrolides (MIC less than 1 microgram/ml). Nevertheless, some of the strains recently isolated in our laboratories showed moderate to high levels of resistance (MICs ranging from 2 micrograms/ml to 100 micrograms/ml). In particular, a strain (CT28) isolated from a patient with nongonococcal urethritis long treated with erythromycin revealed a MIC greater than 100 micrograms/ml for this antibiotic. In order to investigate the mechanisms of resistance, strain CT28 and ten clinical and laboratory U. urealyticum strains were compared for the sensitivity to six antibiotics including three macrolides. Moreover the amount of macrolide uptake and the specific antibiotic binding to ribosomes were studied. Strain CT28 was resistant to josamycin, erythromycin, roxithromycin, lincomycin and clindamycin but sensitive to minocycline. When compared to a sensitive strain, strain CT28 showed a six-fold reduction in intracellular macrolide influx and accumulation and a reduction in antibiotic binding to ribosomes. The mechanisms implicated in these differences may be important for macrolide resistance in U. urealyticum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2767221     DOI: 10.1007/BF00156820

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  43 in total

1.  In vitro susceptibility studies with josamycin and erythromycin.

Authors:  L J Strausbaugh; J A Dilworth; J M Gwaltney; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1976-03       Impact factor: 5.191

2.  Ureaplasmal pneumonia and sepsis associated with persistent pulmonary hypertension of the newborn.

Authors:  K B Waites; D T Crouse; J B Philips; K C Canupp; G H Cassell
Journal:  Pediatrics       Date:  1989-01       Impact factor: 7.124

3.  Rosamicin, a macrolide with in vitro activity against Ureaplasma urealyticum.

Authors:  A C Hill; G Sutton
Journal:  J Antibiot (Tokyo)       Date:  1979-09       Impact factor: 2.649

4.  Antibiotic resistance mutations in 16S and 23S ribosomal RNA genes of Escherichia coli.

Authors:  C D Sigmund; M Ettayebi; E A Morgan
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

5.  Modified metabolic inhibition test for serotyping strains of Ureaplasma urealyticum (T-strain Mycoplasma).

Authors:  J A Robertson; G W Stemke
Journal:  J Clin Microbiol       Date:  1979-06       Impact factor: 5.948

Review 6.  A review of the in-vitro activity of roxithromycin against genital pathogens.

Authors:  G L Ridgway
Journal:  J Antimicrob Chemother       Date:  1987-11       Impact factor: 5.790

7.  T-strain Mycoplasma. Selective inhibition by erythromycin in vitro.

Authors:  M C Shepard; C D Lunceford; R L Baker
Journal:  Br J Vener Dis       Date:  1966-03

8.  Ureaplasma urealyticum causing persistent urethritis in a patient with hypogammaglobulinaemia.

Authors:  D Taylor-Robinson; P M Furr; A D Webster
Journal:  Genitourin Med       Date:  1985-12

9.  Tetracycline-resistant Mycoplasma hominis strains contain streptococcal tetM sequences.

Authors:  M C Roberts; L A Koutsky; K K Holmes; D J LeBlanc; G E Kenny
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

10.  Susceptibility of genital mycoplasmas to antimicrobial agents.

Authors:  P Braun; J O Klein; E H Kass
Journal:  Appl Microbiol       Date:  1970-01
View more
  7 in total

1.  Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans.

Authors:  Ankit Bharat; Scott A Cunningham; G R Scott Budinger; Daniel Kreisel; Charl J DeWet; Andrew E Gelman; Ken Waites; Donna Crabb; Li Xiao; Sangeeta Bhorade; Namasivayam Ambalavanan; Daniel F Dilling; Erin M Lowery; Todd Astor; Ramsey Hachem; Alexander S Krupnick; Malcolm M DeCamp; Michael G Ison; Robin Patel
Journal:  Sci Transl Med       Date:  2015-04-22       Impact factor: 17.956

Review 2.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

Review 3.  Mycoplasmas and ureaplasmas as neonatal pathogens.

Authors:  Ken B Waites; Brenda Katz; Robert L Schelonka
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

4.  Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.

Authors:  Michael L Beeton; Victoria J Chalker; Nicola C Maxwell; Sailesh Kotecha; O Brad Spiller
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

Review 5.  Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.

Authors:  G H Cassell; K B Waites; H L Watson; D T Crouse; R Harasawa
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

6.  Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Authors:  T S Lucier; K Heitzman; S K Liu; P C Hu
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

7.  Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants.

Authors:  R John Baier; John Loggins; Thomas E Kruger
Journal:  BMC Pediatr       Date:  2003-09-04       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.